Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study: Tele-HCV Treatment Trial

NCT04798521 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT04798521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study: Tele-HCV Treatment Trial
Lead sponsor
Oregon Health and Science University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2020
Completion date
January 10, 2024
Enrollment
203 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c